结果:全组患者中,中期PET-CT评价为有效组[完全缓解(complete response,CR)+部分缓解(partial response,PR)]和无效组[疾病稳定(stable disease,SD)+疾病进展(progression of disease,PD)]患者分别为30例和8例.全组患者的中位总生存期(median overall survival,mOS)和无进展生存期(progression free survival,PFS)...